Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002

M.F. Ernst; L.V. van de Poll-Franse; J.A. Roukema; J.W.W. Coebergh; C.M.J. van Gestel; G. Vreugdenhil; M.J. Louwman; A.C. Voogd

doi:10.1016/j.breast.2007.01.001

Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002

M.F. Ernst, L.V. van de Poll-Franse, J.A. Roukema, J.W.W. Coebergh, C.M.J. van Gestel, G. Vreugdenhil, M.J. Louwman, A.C. Voogd^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

We performed a population-based study, including 1089 patients with primary metastatic breast cancer, diagnosed in South-East Netherlands between 1975 and 2002, and tried to give an answer to the question if prognosis of this patient group has improved or not. Follow-up was completed until 1 January 2005. The median survival times for patients with primary metastatic disease were 18, 17 and 20.5 months for patients diagnosed in the periods 1975-1984, 1985-1994 and 1995-2002, respectively. A multivariate analysis, including age, tumour size and information on the localization of metastatic disease and the number of metastatic sites, showed that patients diagnosed in the period 1995-2002 had a 18% tower death risk (95% confidence interval 5-30) compared to those diagnosed in the period 1985-1994. These data show that the prognosis of patients with primary metastatic breast cancer remained unchanged between 1975 and 1994 and that some progress has been made after 1994.

Original language	English
Pages (from-to)	344-51
Journal	Breast
Volume	16
Issue number	4
DOIs	https://doi.org/10.1016/j.breast.2007.01.001
Publication status	Published - 1 Jan 2007

Access to Document

10.1016/j.breast.2007.01.001

Cite this

@article{f411e75834c641079ce5d6f410413f07,

title = "Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002",

abstract = "We performed a population-based study, including 1089 patients with primary metastatic breast cancer, diagnosed in South-East Netherlands between 1975 and 2002, and tried to give an answer to the question if prognosis of this patient group has improved or not. Follow-up was completed until 1 January 2005. The median survival times for patients with primary metastatic disease were 18, 17 and 20.5 months for patients diagnosed in the periods 1975-1984, 1985-1994 and 1995-2002, respectively. A multivariate analysis, including age, tumour size and information on the localization of metastatic disease and the number of metastatic sites, showed that patients diagnosed in the period 1995-2002 had a 18% tower death risk (95% confidence interval 5-30) compared to those diagnosed in the period 1985-1994. These data show that the prognosis of patients with primary metastatic breast cancer remained unchanged between 1975 and 1994 and that some progress has been made after 1994. ",

author = "M.F. Ernst and {van de Poll-Franse}, L.V. and J.A. Roukema and J.W.W. Coebergh and {van Gestel}, C.M.J. and G. Vreugdenhil and M.J. Louwman and A.C. Voogd",

year = "2007",

month = jan,

day = "1",

doi = "10.1016/j.breast.2007.01.001",

language = "English",

volume = "16",

pages = "344--51",

journal = "Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

number = "4",

}

TY - JOUR

T1 - Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002

AU - Ernst, M.F.

AU - van de Poll-Franse, L.V.

AU - Roukema, J.A.

AU - Coebergh, J.W.W.

AU - van Gestel, C.M.J.

AU - Vreugdenhil, G.

AU - Louwman, M.J.

AU - Voogd, A.C.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - We performed a population-based study, including 1089 patients with primary metastatic breast cancer, diagnosed in South-East Netherlands between 1975 and 2002, and tried to give an answer to the question if prognosis of this patient group has improved or not. Follow-up was completed until 1 January 2005. The median survival times for patients with primary metastatic disease were 18, 17 and 20.5 months for patients diagnosed in the periods 1975-1984, 1985-1994 and 1995-2002, respectively. A multivariate analysis, including age, tumour size and information on the localization of metastatic disease and the number of metastatic sites, showed that patients diagnosed in the period 1995-2002 had a 18% tower death risk (95% confidence interval 5-30) compared to those diagnosed in the period 1985-1994. These data show that the prognosis of patients with primary metastatic breast cancer remained unchanged between 1975 and 1994 and that some progress has been made after 1994.

AB - We performed a population-based study, including 1089 patients with primary metastatic breast cancer, diagnosed in South-East Netherlands between 1975 and 2002, and tried to give an answer to the question if prognosis of this patient group has improved or not. Follow-up was completed until 1 January 2005. The median survival times for patients with primary metastatic disease were 18, 17 and 20.5 months for patients diagnosed in the periods 1975-1984, 1985-1994 and 1995-2002, respectively. A multivariate analysis, including age, tumour size and information on the localization of metastatic disease and the number of metastatic sites, showed that patients diagnosed in the period 1995-2002 had a 18% tower death risk (95% confidence interval 5-30) compared to those diagnosed in the period 1985-1994. These data show that the prognosis of patients with primary metastatic breast cancer remained unchanged between 1975 and 1994 and that some progress has been made after 1994.

U2 - 10.1016/j.breast.2007.01.001

DO - 10.1016/j.breast.2007.01.001

M3 - Article

C2 - 17303426

SN - 0960-9776

VL - 16

SP - 344

EP - 351

JO - Breast

JF - Breast

IS - 4

ER -